Vytora Health logo

Vytora Health Review

8.4
★★★★☆4.2/5

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.4/10

Best for: compounded or brand-name GLP-1 with named pharmacy partners, 50 states

Vytora Health scores highest on the strength of its clinical program: drug options and dosing support.

Semaglutide

$179/mo

Tirzepatide

$249/mo

Price checked on Vytora Health’s site,

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not stated

Coaching

Not stated

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

Vytora Health is a 50-state-plus-DC telehealth platform offering compounded semaglutide ($179/mo) and tirzepatide ($249/mo), with cheaper 3-month plans billed upfront, plus brand-name Mounjaro and Zepbound at $1,399/mo. It publicly names its clinical group (Wasef Health, PC) and compounding pharmacies (Vials Pharmacy and Hallandale Pharmacy). Pricing is all-inclusive and plans renew automatically until you cancel.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedBrandZepboundMounjaroLegitScript VerifiedHIPAA CompliantAll 50 StatesVideo Visit

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Vetted alternatives to Vytora Health

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
“starting at” price
$129/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
Vytora Health logo
4.2 / 5
Our editorial rating
Visit Vytora Health →

from $179/mo · no insurance needed

Vytora Health at a glance

Type
GLP-1 telehealth provider
Medications
Zepbound, Mounjaro
Starting price
$179/mo
What's included
Medication · Consult · Shipping
Availability
All 50 states
FDA status
No FDA warning letter on record

How we scored Vytora Health

Each dimension is scored algorithmically from Vytora Health’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

8.2/10

At $179/mo, Vytora Health runs in line with the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).

Effectiveness25%

9.1/10

Vytora Health offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions.

User Experience15%

8.1/10

Online intake and platform experience (consult included in the price); 8 platform features disclosed.

Trust & Safety15%

8.8/10

Key details fully confirmed by our editors; no FDA warning letters on file.

Accessibility10%

9.0/10

Vytora Health treats patients in all 50 states plus DC.

Support10%

6.6/10

Vytora Health provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
671providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Vytora Health review

Last checked October 2026
  • Confirmed current pricing across 4 dose/plan tiers
  • Confirmed availability in all 50 states plus DC
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.

What we checked

Provider's own pricing page
$179–$1,399/mo across 4 dose/plan tiers (checked October 2026)
State pharmacy licensing & LegitScript status
LegitScript Verified
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with Vytora Health

We walked Vytora Health’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Compare plans on the homepage, toggling between 1-month and 3-month pricing.
  2. 2Click 'Get started' on a treatment card.
  3. 3The intake asks for your email address or to create an account before any health questions.
Price shown before you start
  • Prices are shown upfront: semaglutide $179/mo or $149/mo on a 3-month plan billed $447; tirzepatide $249/mo or $199/mo on a 3-month plan billed $599.
  • Brand-name Mounjaro and Zepbound are listed at $1,399 a month, month-to-month.
  • Pricing is described as all-inclusive with no membership fee and free shipping on every refill.
  • Plans renew automatically; you cancel by emailing support before your next renewal date.
  • The refund policy says all sales are final, while the FAQ says refund requests are reviewed case by case.
  • Five states (Kansas, Louisiana, Mississippi, New Mexico, West Virginia) require a brief video or audio visit before treatment.

Vytora Health customer support

GLP-1 medications Vytora Health offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Peptides Vytora Health offers

Beyond GLP-1s, Vytora Health also offers these peptides. Tap any for our evidence-based guide.

Pricing

Prices re-verified

Month-to-month (auto-renews monthly)Compounded
$179/mo
semaglutide

$179/mo month-to-month, all-inclusive (medication, consult, supplies, shipping). Longer plans: 3-mo $149/mo ($447 every 3 months).

Month-to-month (auto-renews monthly)Compounded
$249/mo
tirzepatide

$249/mo month-to-month, all-inclusive. Longer plans: 3-mo $199/mo ($599 every 3 months).

Brand Mounjaro pen, month-to-monthBrand-name
$1,399/mo
tirzepatide

$1,399/mo month-to-month at retail pricing; includes provider visits and free shipping.

Brand Zepbound pen, month-to-monthBrand-name
$1,399/mo
tirzepatide

$1,399/mo month-to-month at retail pricing; includes provider visits and free shipping.

Ready to get started?

Plans and promotions change often, so check Vytora Health's current pricing and active discounts before you decide.

See Vytora Health pricing →

What we like

  • All 50 states plus DC, with the few states that need a video or audio visit named upfront
  • Both compounded and brand-name options on one platform
  • Displays a LegitScript seal and says it is HIPAA compliant
  • Names its pharmacies (Vials Pharmacy in Houston, Hallandale Pharmacy in Fort Lauderdale) and its physician group
  • All-inclusive pricing: medication, consult, supplies, shipping and provider support, no membership fee
  • 3-month plans cut the price to $149/mo for semaglutide and $199/mo for tirzepatide

Watch-outs

  • Brand-name Mounjaro and Zepbound at $1,399/mo are priced at retail; manufacturer self-pay programs are often cheaper
  • Compounded tirzepatide at $249/mo month-to-month is mid-market
  • Plans renew automatically until you email support to cancel
  • All sales are final; refunds are only reviewed case by case
  • Dose-by-dose pricing isn't listed, and the fine print says prices may vary by dosage
  • 3-month plans are billed upfront ($447 or $599)
  • Email is required before you see any intake questions

Vytora Health: the rare telehealth brand that names its pharmacy and its doctors

Most compounded-GLP-1 startups keep two things hidden: which pharmacy fills your vials, and which physician group is signing your prescriptions. Vytora Health publishes both on its own site, and that single decision is the strongest reason to consider it. If you want a 50-state platform where you can run semaglutide or tirzepatide at a fair monthly price, and still trade up to FDA-approved brand pens later without switching providers, Vytora is a sensible pick. Its weak point is brand-name pricing.

How the pricing works

Vytora bills by plan length, not by dose, and every plan is all-inclusive: medication, the physician consultation, supplies, free shipping, and ongoing provider support, with no hidden fees layered on at checkout. Compounded semaglutide runs $179 a month on the month-to-month plan, or $149 a month on a three-month plan billed $447 up front. Compounded tirzepatide is $249 month to month, or $199 a month on a three-month plan billed $599. The longer plans save roughly 17% to 20%. But they bill the full quarter up front, so you put more money down to get the lower monthly figure.

For reference, the category median we track lands around $179 a month, so Vytora's month-to-month semaglutide sits close to the middle while its tirzepatide is mid-pack rather than a bargain. There's no teaser first-month rate here. The discount comes from the three-month plan, not a promo.

How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.

  • Best value: compounded semaglutide on the three-month plan at $149/mo
  • Mid-market: compounded tirzepatide, solid but above the cheapest floor in the category
  • Premium: brand-name Mounjaro and Zepbound, priced near retail (see the caveat below)

What you can get: compounded, brand, and peptides

Vytora is one of the few platforms carrying both compounded and brand-name options side by side. On the compounded side you get semaglutide and tirzepatide. On the brand side, Vytora can prescribe FDA-approved Mounjaro and Zepbound, useful if you'd rather have the manufacturer's pen than a compounded vial, or if compounded supply tightens. It also offers NAD+ and sermorelin peptides for people exploring those separately, though those sit outside the weight-loss core.

Dosing is clinician-led: a provider escalates your dose over time. Vytora doesn't publish a dose-by-dose price list, though. Its fine print says prices may vary by dosage, so confirm what your maintenance dose will cost before you commit to a longer plan. By contrast, Navio MD publishes how its compounded tirzepatide price changes by dose, and it barely moves, but it sells no semaglutide.

The differentiator: published pharmacy and physician disclosure

Vytora names Vials Pharmacy in Houston and Hallandale Pharmacy in Fort Lauderdale as its compounding partners in public. Most of its competitors won't do that. It also discloses the physician group behind the prescriptions: Wasef Health, PC, out of Pinellas Park, Florida. For a category where 'who is responsible for my care' is usually a black box, being able to look up the pharmacy and the supervising doctor is meaningful transparency, and it's why the trust signals here rate above average.

For context, Wasef Health is a multi-brand telehealth physician group that also prescribes for several other unrelated DTC platforms. There's no shared pharmacy or corporate overlap with Vytora itself. This is the normal 'moonlighting clinical-services group' pattern, not a red flag, but the doctors aren't exclusive to Vytora.

Coverage and compliance

Vytora operates in all 50 states plus Washington, DC, and it names the states with extra steps upfront. In Kansas, Louisiana, Mississippi, New Mexico, and West Virginia, you need a brief video or audio visit before treatment starts. It displays a LegitScript seal and says it is HIPAA compliant. We have no FDA warning letter on file for Vytora.

Where it falls short

The brand-name option is the weak spot. Mounjaro and Zepbound through Vytora are priced near full retail, well over a thousand dollars a month. That means most patients who want the brand pens would do better buying direct from the manufacturer's self-pay program, where the same brands often run a few hundred dollars a month. Treat Vytora's brand offering as a convenience for staying on one platform, not as a way to save money.

Billing is the other thing to read closely. Every plan renews automatically, and you cancel by emailing support before your next renewal date. The refund page says all sales are final, while the FAQ says refund requests are reviewed case by case. Plan on not getting money back once a fill ships. There is also OrderlyMeds, which avoids the renewal problem by charging only when you request a refill, but its orders can't be canceled once a prescription is written.

  • Brand pricing is near retail: manufacturer self-pay programs usually beat it by hundreds a month
  • Compounded tirzepatide is mid-market, not the cheapest available
  • Plans auto-renew until you email support, and all sales are final
  • No dose-by-dose price list, and the fine print says prices may vary by dosage
  • Three-month plans bill the full quarter up front to get the lower monthly rate
  • Per-prescriber state licensing detail is limited, even though the clinical group is named

Who should choose Vytora, and who should skip it

Choose Vytora if transparency is your priority: you want to know your pharmacy and your physician group by name, you value all-inclusive pricing with no surprise fees, and you want the flexibility to move between compounded and brand-name later. It's also a strong fit if you live in a state other providers don't reach, given the full 50-state-plus-DC footprint.

Skip it if your only goal is the rock-bottom price on compounded tirzepatide, or if you specifically want brand-name pens cheaply; in both cases another route will cost you less. You can see how we weigh price, transparency, and oversight on our scoring methodology page.

Bottom line

Vytora Health earns its place by doing what most of the category won't: telling you who fills your prescription and who prescribes it, in plain sight, across every state. Its compounded semaglutide is fairly priced, its all-inclusive billing is free of nickel-and-dime fees, and its trust signals are solid. Just go in clear-eyed that the brand-name pens are a premium-priced convenience, and the tirzepatide is fair rather than cheap. Transparency-minded patients may accept that trade.

The Bottom Line

Vytora Health scores highest on the strength of its clinical program: drug options and dosing support.

Score: 8.4/10Best for: compounded or brand-name GLP-1 with named pharmacy partners, 50 statesFrom: $179/mo

Ready to start with Vytora Health?

From $179/mo. See current pricing and start your free consultation.

Vytora Health might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If the lowest possible monthly price is your top priority, consider YourEra (from $89/mo).
  • If you want built-in coaching and behavior-change support, consider Ro.

Head-to-head

Compare Vytora Health vs…

Vytora Health scores8.4/10

Side-by-side pricing, medications and scores. Pick a matchup.

More Vytora Health comparisons

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

Vytora Health is a telehealth platform available in all 50 states plus DC that offers compounded semaglutide and tirzepatide alongside brand-name Mounjaro and Zepbound, plus NAD+ and sermorelin. It displays a LegitScript seal and publicly names its physician group (Wasef Health, PC) and its compounding pharmacies (Vials Pharmacy and Hallandale Pharmacy).
Both. Vytora carries FDA-approved brand-name Mounjaro and Zepbound as well as compounded semaglutide and tirzepatide on the same platform. Compounded medications are prepared by a compounding pharmacy and are not FDA-approved finished products; a licensed clinician determines whether either option is appropriate for you.
Compounded semaglutide is $179 a month month-to-month, or $149 a month on a 3-month plan billed $447 upfront. Compounded tirzepatide is $249 a month, or $199 a month on a 3-month plan billed $599. Brand-name Mounjaro and Zepbound are $1,399 a month, which is retail pricing; manufacturer self-pay programs may cost less.
Vytora reports availability across all 50 states plus Washington, DC. The visit format can vary by state (some require a video visit while a few accept an audio consultation), so the exact intake process may differ depending on where you live.
Vytora operates as a cash-pay telehealth service, and the listed monthly prices are what you pay directly. It does not bill insurance for compounded medication, though its pricing is described as all-inclusive, covering the medication, clinician care, supplies, and shipping.
Choose a plan, then create an account with your email and complete the online intake; a licensed clinician reviews your information and decides whether a GLP-1 is appropriate, so a prescription is not guaranteed. Plans renew automatically, and you can cancel by emailing support@vytorahealth.com before your next renewal date; prescription sales are final.
Vytora Health doesn't use public promo or coupon codes: its $179/month includes the medication and the clinician visits, with no insurance or coupons needed. Third-party sites advertising "Vytora Health discount codes" are typically fake; any current offer applies automatically through the link on this page.
Vytora Health is an operating telehealth provider, and we found no FDA warning letter on file for it. On its public pages, it shows LegitScript certification. We last checked its prices and policies on its own site in October 2026. We scored it 8.4/10 from published information, which is not a clinical endorsement. Talk to a licensed clinician before starting any medication.
We don't collect customer complaints, so this covers what our own review found. There is no FDA warning letter on file for Vytora Health. The concerns our review flags: Brand-name Mounjaro and Zepbound at $1,399/mo are priced at retail; manufacturer self-pay programs are often cheaper; Compounded tirzepatide at $249/mo month-to-month is mid-market; Plans renew automatically until you email support to cancel; All sales are final; refunds are only reviewed case by case. Weigh them before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Vytora Health review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See Vytora Health's current pricing

Plans from $179/mo. Start your free consultation to check eligibility and today's price.